View Older Stories View More Recent Stories
-
IDEAYA and Genentech to test drug combo in pancreatic cancer
-
IBM links two cryogenic quantum modules in step toward 2029 goal
-
Cerebras launches CS-4 AI accelerator built on three wafer-scale chips
-
AIxC pivots to robot-sharing as RoboShare logs first paid order
-
Freedom Holding unit gets Turkish brokerage license, first in 34 years
-
Vision Marine and Avikus begin electric boat navigation integration
-
EHang launches eVTOL fast-track program with Sri Lanka as first market
-
F3 Welcomes Mr. Ross McElroy as Strategic Advisor
-
This cyberstock is best-positioned in a post-quantum world
-
Who is the Best Facial Feminization Surgeon in the World?
-
F4 Stakes New Drill-Ready Project at Kelic Lake
-
Who Does the Best Male Facelift Surgery in Sarasota?
-
Orecap Receives TSXV Acceptance for Stardust Agreement on McGarry Gold Project
-
Barclays sees European diesel refining margins at 5-6x normal levels
-
Klarna shares draw top investor interest at Wolfe amid fintech positioning shift
-
Diamond Consulate to Open Private Fine Jewelry and Custom Engagement Ring Showroom in Oklahoma City
-
Needham on Klarna (KLAR): 'Shares Back to the Penalty Box'
-
Avita Medical Ltd. (RCEL) PT Raised to $11 at BTIG
-
Evercore says mutual funds cut bank stock holdings in second quarter
-
Morgan Stanley names top stock picks after India earnings season
-
Citi analyzes positioning in US chemicals stocks
-
Klarna (KLAR) PT Lowered to $17 at Morgan Stanley
-
BMO Capital Starts Prime Medicine (PRME) at Outperform
-
BMO Capital Starts Perspective Therapeutics Inc (CATX) at Outperform
-
Wolfe Research Starts AFLAC (AFL) at Underperform
-
BMO Capital Starts Ionis Pharmaceuticals (IONS) at Market Perform
-
BMO Capital Starts Exelixis (EXEL) at Market Perform
-
BMO Capital Starts BioMarin Pharmaceutical Inc. (BMRN) at Outperform
-
BMO Capital Starts Aktis Oncology (AKTS) at Outperform
-
BMO Capital Starts Bicara Therapeutics Inc (BCAX) at Outperform
-
BMO Capital Starts Alnylam Pharmaceuticals (ALNY) at Outperform
-
BMO Capital Starts Ascendis Pharma (ASND) at Outperform
-
Goldman Sachs Assumes Cricut, Inc. (CRCT) at Sell
-
Goldman Sachs Assumes Cosair Gaming (CRSR) at Sell
-
BofA Adjusts US 1 List
-
Barclays on Workday (WDAY): 'we see volatility risk if WDAY comments on Reuters' acquisition news'
-
Barclays Previews Autodesk (ADSK) Earnings
-
Mizuho on Upstart Holdings Inc (UPST) Post Mgmt. Meet: 'We walked away still feeling upbeat about the story'
-
Morgan Stanley on Snowflake Inc. (SNOW): 'Constructive checks support ~34% 2Q Product rev growth and a FY27 raise to 32-33%'
-
Increasing unusual put option volume: BNY XLB BNY WOLF KEYS IREX PAGP VIK IEP TOL FN
-
Klarna (KLAR) PT Lowered to $16 at Bernstein SocGen Group
-
Increasing unusual call option volume: AS CMPX HAS PLNT XP VWO MPC LSCC DUOT KEYS SPYI JETS
-
Raymond James Reiterates Outperform Rating on FedEx Freight Holding Company (FDXF)
-
Increasing unusual option volume: AS CMPX EYPT XLB XEL KC HAS PLNT VWO DUOT
-
Global S&P Futures mixed in premarket
-
VNET Group Inc (VNET) PT Lowered to $14 at Morgan Stanley
-
Active options: AMD MSFT PLTR SNDK CRWV AVGO NKE GOOGL WOLF MSTR NBIS
-
Active options: NVDA TSLA AAPL INTC MU META SPCX AMZN NFLX
-
BofA Securities Upgrades Solaria Energia y Medio Ambiente SA (SLR:SM) to Buy
-
Popular stocks with increasing option volume: INTC MU SPCX NFLX PLTR SNDK CRWV AVGO NKE WOLF MSTR
